Clinical experience with adverse reactions to trimethoprim-sulfamethoxazole.
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced; D000741:Anemia, Aplastic / Q000139:chemically induced; D000748:Anemia, Macrocytic / Q000139:chemically induced; D002648:Child; D003863:Depression / Q000139:chemically induced; D004338:Drug Combinations; D003875:Drug Eruptions / Q000209:etiology; D004739:England; D005494:Folic Acid Deficiency / Q000139:chemically induced; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006212:Hallucinations / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007970:Leukopenia / Q000139:chemically induced; D008875:Middle Aged; D012042:Registries; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced; D014295:Trimethoprim / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole